Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Unknown 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 10Gastrointestinal 6Thoracic 4Lymphoid 3Other 2Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Obesity 60Neoplasms 20Overweight 17Polycystic Ovary Syndrome 11Dyspnea 10Sexual Dysfunction, Physiological 9Prostatic Neoplasms 7Motor Activity 7Hypertension 7Endometrial Neoplasms 7Breast Neoplasms 7Diabetes Mellitus, Type 2 6Mucositis 5Metabolic Syndrome 5Diabetes Mellitus 5Pulmonary Disease, Chronic Obstructive 4Lung Neoplasms 4Depression 4Constipation 4Cardiovascular Diseases 4Weight Loss 3Stomatitis 3Renal Insufficiency, Chronic 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Opioid-Induced Constipation 3Non-alcoholic Fatty Liver Disease 3Myasthenia Gravis 3Insulin Resistance 3Heart Failure 3Endometrial Hyperplasia 3

Interventions

Tablets 1Specimen Handling 1Pregabalin 1Omeprazole 1Ketorolac 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Inflammation × Other × Clear all
NCT07189806 2025-09-24

MAPLE-UK

Hvivo

Recruiting
250 enrolled
LymphoidOtherThoracic

Asthma, Bronchial Spasm, Cough, Disease, Dyspnea, Inflammation, Lymphoma, Follicular

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting
112 enrolled
BreastOther

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡